Delivery Order SPE2DR25D3005-SPE2DR26FP8NU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $2,485.81 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,858.06 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18 count) with a completion date of June 2, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (36-count packages) with a ceiling value of $3,390.15. This non-competitive, firm fixed-price delivery order is scheduled for completion by December 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.85 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical supply order fulfilling federal medical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,167.50 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (36-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for ultimate completion on November 19, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $1,059.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,491.32 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18 count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,196.95 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside contract utilizes firm fixed-price pricing and represents a small-value pharmaceutical procurement from the awardee's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8NUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Mucinex D ER 600-60 mg tablets (36-count) at a fixed price of $1,194.52, with completion scheduled for January 13, 2026. This non-set-aside, competitively awarded contract represents a task order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying medications and medical supplies across multiple therapeutic domains to military healthcare systems and veteran programs. The delivery order exemplifies the pharmaceutical supply chain support that AmerisourceBergen provides through its comprehensive IDC vehicle, which enables flexible fulfillment of medical commodities required by the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The parent company, Cencora, Inc. (operating as AmerisourceBergen), maintains multiple large-value federal contracts with the DLA and Department of Justice, demonstrating sustained capability to meet government pharmaceutical procurement requirements through open competition on a national and global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/11/26 |